QA102

Smilebiotek Zhuhai Limited · Phase 2 active Small molecule

At a glance

Generic name	QA102
Sponsor	Smilebiotek Zhuhai Limited
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

QA102 Phase II Study in Subjects With Dry AMD (PHASE2)
QA102 Phase 1 Study in Healthy Young and Older Adult Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

QA102 CI brief — competitive landscape report
QA102 updates RSS · CI watch RSS
Smilebiotek Zhuhai Limited portfolio CI